DiaMedica Therapeutics (DMAC) EPS (2018 - 2026)
DiaMedica Therapeutics (DMAC) EPS from Dec 31, 2018 to Mar 31, 2026. The TTM DiaMedica Therapeutics (DMAC) EPS is -$0.69. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
DiaMedica Therapeutics (DMAC) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +9.88% |
| 3 Years TTM | +5.90% |
| 5 Years TTM | -1.86% |
| All Time TTM | -3.89% |
Annual EPS change of DiaMedica Therapeutics (DMAC)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.19 | -69.44% |
| 2025 | -$0.61 | +6.83% |
| 2024 | -$0.57 | +11.79% |
| 2023 | -$0.51 | -1.31% |
| 2022 | -$0.52 | +0.66% |
| 2021 | -$0.51 | -21.61% |
| 2020 | -$0.66 | -26.09% |
| 2019 | -$0.89 | +85.09% |
| 2018 | -$0.48 | -28.33% |
| 2017 | -$0.67 | N/A |
Comparison DiaMedica Therapeutics (DMAC) five years EPS CAGR with competitors
DiaMedica Therapeutics (DMAC) five years EPS CAGR is -1.88%.